Demo Sign up Log In

Heron Therapeutics Inc (HRTX)

Financing Cash Flow

$13.61M

TTM · Period ending: Jun 30, 2026 · USD

HRTX Financing Cash Flow

Latest reported$13.61Mperiod endingJun 30, 2026

Latest reported$13.61Mperiod endingJun 30, 2026

HRTX TTM Cash from Financing ($2.20M → $13.61M)

TTM financing cash flow

High-resolution chart · PNG

HRTX financing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Heron Therapeutics Inc Financing Cash Flow — Trailing twelve months (TTM) (USD)
Period ending	Financing Cash Flow (USD)
Jun 30, 2001	-2,804,629
Mar 31, 2001	-2,976,476
Dec 31, 2000	-3,067,868
Sep 30, 2000	21,395,551
Jun 30, 2000	-734,605
Mar 31, 2000	-891,392
Dec 31, 1999	600,000
Sep 30, 1999	500,000
Jun 30, 1999	-100,000
Mar 31, 1999	0
Dec 31, 1998	-300,000
Sep 30, 1998	1,500,000
Jun 30, 1998	3,700,000
Mar 31, 1998	5,400,000
Dec 31, 1997	4,600,000
Sep 30, 1997	2,100,000
Jun 30, 1997	1,400,000
Mar 31, 1997	3,200,000
Dec 31, 1996	7,100,000
Sep 30, 1996	9,500,000
Jul 25, 1996	15,400,000
Mar 31, 1996	12,200,000
Dec 31, 1995	9,600,000
Sep 30, 1995	9,400,000
Jun 30, 1995	4,100,000
Mar 31, 1995	10,300,000
Dec 31, 1994	10,500,000
Sep 30, 1994	9,400,000
Jun 30, 1994	8,000,000
Mar 31, 1994	1,700,000
Dec 31, 1993	-100,000
Sep 30, 1993	400,000
Jun 30, 1993	4,500,000
Mar 31, 1993	8,500,000
Dec 31, 1992	19,500,000
Sep 30, 1992	20,800,000
Jun 30, 1992	16,900,000
Mar 31, 1992	13,100,000
Dec 31, 1991	2,100,000
Sep 30, 1991	2,000,000
Jun 30, 1991	1,700,000
Mar 31, 1991	2,100,000
Dec 31, 1990	2,200,000
Sep 30, 1990	700,000
Jun 30, 1990	700,000

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.